NCT03120013 Rehabilitative Trial With Cerebello-Spinal tDCS in Neurodegenerative Ataxia Status COMPLETED Phase NA
NCT03076671 More Than a Movement Disorder: Applying Palliative Care to Parkinson's Disease Status COMPLETED Phase NA
NCT03042988 Overnight Trials With Heat Stress in Autonomic Failure Patients With Supine Hypertension Status RECRUITING Phase NA
NCT02897063 Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure Status RECRUITING Phase PHASE1
NCT02726711 Reduction in Splanchnic Capacitance Contributes to Sympathetically Dependent Hypertension in Autonomic Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02640339 Retinal Abnormalities as Biomarker of Disease Progression and Early Diagnosis of Parkinson Disease Status COMPLETED Phase N/A
NCT02445469 Magnetic Resonance Imaging in the Diagnosis of Parkinsonian Syndromes Status TERMINATED Phase NA
NCT02429557 Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure Status COMPLETED Phase PHASE1
NCT02428816 Evaluation of a Multimodal Neuroimaging Method for Diagnosis in Parkinsonian Syndromes Status COMPLETED Phase NA
NCT02417415 Local Heat Stress in Autonomic Failure Patients With Supine Hypertension Status COMPLETED Phase NA
NCT02270489 Study Assessing Safety and Therapeutic Activity of AFFITOPE® PD01A and PD03A in Patients With Early MSA Status COMPLETED Phase PHASE1
NCT02185677 Cognitive and Behavioral Dysexecutive Syndrome in Multiple System Atrophy Status COMPLETED Phase N/A
NCT02132052 Defining Phenotypes of Movement Disorders :Parkinson's Plus Disorders (PD), Essential Tremor (ET), Cortical Basal Degeneration (CBD), Multiple Systems Atrophy (MSA), Magnetoencephalography. Status COMPLETED Phase N/A
NCT02071459 Efficacy of L-threo DOPS on Orthostatic Hypotension Symptoms and Other Non-motor Symptoms in Patients With MSA Status COMPLETED Phase PHASE2/PHASE3
NCT02064166 Treatment of Parkinson Disease and Multiple System Atrophy Using Intranasal Insulin. Status COMPLETED Phase PHASE2
NCT02008721 Progression Rate of MSA Under EGCG Supplementation as Anti-Aggregation-Approach Status COMPLETED Phase PHASE3